Zydus Cadila receives ANDA approval for Dextromphetamine
Nesher Pharmaceuticals, an arm of Zydus Pharmaceuticals USA has received its first Abbreviated New Drug Application (ANDA) approval from the US FDA to market Dextroamphetamine […]
Cadila
Cadila Healthcare receives USFDA approval for Acylovir capsules
Cadila Healthcare has received USFDA approval for its anti-viral generic drug Acyclovir capsules Acyclovir capsules to market the same in the American market. The drug […]
Zydus Cadila receives USFDA approval for Glyburide and Metformin HCL tablets
Zydus Cadila has received final USFDA approval to sell anti-diabetics Glyburide and Metformin Hcl tablets in in strengths of 1.25/250, 2.5/500 and 5/500 mg in […]
Zydus Cadilat to launch breast cancer drug Vivitra
Zydus Cadila has introduced a breast cancer drug in India, a copy of Swiss giant Roche’s product Herceptin. The company selling a version of trastuzumab […]
Zydus Cadila plans new injectable products facility in Vadodara
Zydus Cadila is planning to set up an injectable products facility at Vadodara in Gujarat. The state-of-the-art facility will come with an investment of Rs. […]
Zydus Cadila receives USFDA approval for Pyridostigmine Bromide
Zydus Cadila has received final approval from the USFDA to market Pyridostigmine Bromide Tablets USP, 60 mg. The tablets are used in treatment of neurological […]